Concepedia

Ryutaro Kanada

RK

4

Publications

93

Citations

4

H-Index

2016

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Ryutaro Kanada is an author at Daiichi-Sankyo (Japan) specializing in chemical biology, medicinal chemistry, and natural sciences.

ORCID

Top concepts

Publications per year

2016–2023

4

Publications

4

Design and Synthesis of Cyclopropane Congeners of Resolvin E2, an Endogenous Proresolving Lipid Mediator, as Its Stable Equivalents

Hayato Fukuda, Ryuta Muromoto, Yuuki Takakura et al. · Organic Letters · 2016 · 30 citations · Full text

, , +17

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

Masashi Numata, Noriyasu Haginoya, Machiko Shiroishi et al. · Cancer Cell International · 2023 · 26 citations · Full text

Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor

Ryutaro Kanada, Yoshiko Kagoshima, Takashi Suzuki et al. · Journal of Medicinal Chemistry · 2022 · 22 citations · Full text

Discovery of EP300/CBP histone acetyltransferase inhibitors through scaffold hopping of 1,4-oxazepane ring

Ryutaro Kanada, Yoshiko Kagoshima, Masayoshi Asano et al. · Bioorganic & Medicinal Chemistry Letters · 2022 · 15 citations · Full text

, , +10

Rows per page

1–4 of 4